VC DEAL ANALYSIS: May breaks through gloom with big-buck deals
This article was originally published in Clinica
Several meaty venture financings – and one particular juicy transaction of nearly $200m – helped push the total deal value in May to more than twice the level in April and make it the most fruitful month this year.
You may also be interested in...ï»¿
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.